ID   MYH10_RAT               Reviewed;        1976 AA.
AC   Q9JLT0;
DT   27-APR-2001, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-2000, sequence version 1.
DT   29-MAY-2024, entry version 161.
DE   RecName: Full=Myosin-10;
DE   AltName: Full=Cellular myosin heavy chain, type B;
DE   AltName: Full=Myosin heavy chain 10;
DE   AltName: Full=Myosin heavy chain, non-muscle IIb;
DE   AltName: Full=Non-muscle myosin heavy chain B;
DE            Short=NMMHC-B;
DE   AltName: Full=Non-muscle myosin heavy chain IIb;
DE            Short=NMMHC II-b;
DE            Short=NMMHC-IIB;
GN   Name=Myh10;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   STRAIN=Sprague-Dawley; TISSUE=Brain;
RX   PubMed=11027611; DOI=10.1006/bbrc.2000.3614;
RA   Yam J.W.P., Chan K.W., Li N., Hsiao W.L.W.;
RT   "Molecular cloning and functional analysis of the promoter region of rat
RT   nonmuscle myosin heavy chain-B gene.";
RL   Biochem. Biophys. Res. Commun. 276:1203-1209(2000).
RN   [2]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1145; SER-1952; SER-1956 AND
RP   SER-1975, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
CC   -!- FUNCTION: Involved with LARP6 in the stabilization of type I collagen
CC       mRNAs for CO1A1 and CO1A2. During cell spreading, plays an important
CC       role in cytoskeleton reorganization, focal contacts formation (in the
CC       central part but not the margins of spreading cells), and lamellipodial
CC       extension; this function is mechanically antagonized by MYH9 (By
CC       similarity). Cellular myosin that appears to play a role in
CC       cytokinesis, cell shape, and specialized functions such as secretion
CC       and capping. {ECO:0000250}.
CC   -!- SUBUNIT: Myosin is a hexameric protein that consists of 2 heavy chain
CC       subunits (MHC), 2 alkali light chain subunits (MLC) and 2 regulatory
CC       light chain subunits (MLC-2). Interacts with PLEKHG6. Interacts with
CC       ECPAS (By similarity). Interacts with KIF26B (By similarity). Interacts
CC       with LARP6. Interacts with MCC. Interacts with CFAP95 (By similarity).
CC       {ECO:0000250|UniProtKB:P35580, ECO:0000250|UniProtKB:Q61879}.
CC   -!- SUBCELLULAR LOCATION: Cell projection, lamellipodium {ECO:0000250}.
CC       Note=Colocalizes with MCC at the leading edge of migrating cells.
CC       {ECO:0000250}.
CC   -!- DOMAIN: The rodlike tail sequence is highly repetitive, showing cycles
CC       of a 28-residue repeat pattern composed of 4 heptapeptides,
CC       characteristic for alpha-helical coiled coils.
CC   -!- PTM: Phosphorylated by ABL2. {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the TRAFAC class myosin-kinesin ATPase
CC       superfamily. Myosin family. {ECO:0000305}.
CC   -!- CAUTION: Represents a conventional non-muscle myosin. This protein
CC       should not be confused with the unconventional myosin-10 (MYO10).
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF139055; AAF61445.1; -; mRNA.
DR   RefSeq; NP_113708.1; NM_031520.1.
DR   AlphaFoldDB; Q9JLT0; -.
DR   SMR; Q9JLT0; -.
DR   BioGRID; 249464; 13.
DR   CORUM; Q9JLT0; -.
DR   IntAct; Q9JLT0; 2.
DR   MINT; Q9JLT0; -.
DR   STRING; 10116.ENSRNOP00000062744; -.
DR   GlyGen; Q9JLT0; 1 site, 1 O-linked glycan (1 site).
DR   iPTMnet; Q9JLT0; -.
DR   PhosphoSitePlus; Q9JLT0; -.
DR   jPOST; Q9JLT0; -.
DR   PaxDb; 10116-ENSRNOP00000062744; -.
DR   GeneID; 79433; -.
DR   KEGG; rno:79433; -.
DR   UCSC; RGD:71000; rat.
DR   AGR; RGD:71000; -.
DR   CTD; 4628; -.
DR   RGD; 71000; Myh10.
DR   eggNOG; KOG0160; Eukaryota.
DR   eggNOG; KOG0161; Eukaryota.
DR   InParanoid; Q9JLT0; -.
DR   OrthoDB; 2877572at2759; -.
DR   PhylomeDB; Q9JLT0; -.
DR   Reactome; R-RNO-5627123; RHO GTPases activate PAKs.
DR   PRO; PR:Q9JLT0; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0042641; C:actomyosin; ISO:RGD.
DR   GO; GO:0030424; C:axon; ISO:RGD.
DR   GO; GO:0005903; C:brush border; ISO:RGD.
DR   GO; GO:0005938; C:cell cortex; ISO:RGD.
DR   GO; GO:0032154; C:cleavage furrow; ISO:RGD.
DR   GO; GO:0005737; C:cytoplasm; ISO:RGD.
DR   GO; GO:0009898; C:cytoplasmic side of plasma membrane; ISO:RGD.
DR   GO; GO:0005829; C:cytosol; ISO:RGD.
DR   GO; GO:0043197; C:dendritic spine; ISO:RGD.
DR   GO; GO:0098978; C:glutamatergic synapse; IDA:SynGO.
DR   GO; GO:0030426; C:growth cone; ISO:RGD.
DR   GO; GO:0030027; C:lamellipodium; IDA:RGD.
DR   GO; GO:0030496; C:midbody; ISO:RGD.
DR   GO; GO:0016459; C:myosin complex; ISO:RGD.
DR   GO; GO:0032982; C:myosin filament; IBA:GO_Central.
DR   GO; GO:0016460; C:myosin II complex; ISO:RGD.
DR   GO; GO:0097513; C:myosin II filament; ISO:RGD.
DR   GO; GO:0031594; C:neuromuscular junction; ISO:RGD.
DR   GO; GO:0043005; C:neuron projection; ISO:RGD.
DR   GO; GO:0043025; C:neuronal cell body; ISO:RGD.
DR   GO; GO:0098871; C:postsynaptic actin cytoskeleton; IDA:SynGO.
DR   GO; GO:0016528; C:sarcoplasm; ISO:RGD.
DR   GO; GO:0005819; C:spindle; ISO:RGD.
DR   GO; GO:0001725; C:stress fiber; ISO:RGD.
DR   GO; GO:0051015; F:actin filament binding; ISO:RGD.
DR   GO; GO:0043531; F:ADP binding; ISO:RGD.
DR   GO; GO:0005524; F:ATP binding; ISO:RGD.
DR   GO; GO:0005516; F:calmodulin binding; IEA:UniProtKB-KW.
DR   GO; GO:0042802; F:identical protein binding; IDA:RGD.
DR   GO; GO:0000146; F:microfilament motor activity; ISO:RGD.
DR   GO; GO:0048027; F:mRNA 5'-UTR binding; ISO:RGD.
DR   GO; GO:0035613; F:RNA stem-loop binding; ISO:RGD.
DR   GO; GO:0030036; P:actin cytoskeleton organization; ISO:RGD.
DR   GO; GO:0051017; P:actin filament bundle assembly; IMP:RGD.
DR   GO; GO:0070650; P:actin filament bundle distribution; IMP:RGD.
DR   GO; GO:0030048; P:actin filament-based movement; ISO:RGD.
DR   GO; GO:0031032; P:actomyosin structure organization; ISO:RGD.
DR   GO; GO:0007512; P:adult heart development; ISO:RGD.
DR   GO; GO:0035904; P:aorta development; ISO:RGD.
DR   GO; GO:0007411; P:axon guidance; ISO:RGD.
DR   GO; GO:0007409; P:axonogenesis; ISO:RGD.
DR   GO; GO:0007420; P:brain development; ISO:RGD.
DR   GO; GO:0060038; P:cardiac muscle cell proliferation; ISO:RGD.
DR   GO; GO:0055003; P:cardiac myofibril assembly; ISO:RGD.
DR   GO; GO:0003279; P:cardiac septum development; ISO:RGD.
DR   GO; GO:0007155; P:cell adhesion; IDA:RGD.
DR   GO; GO:0021680; P:cerebellar Purkinje cell layer development; ISO:RGD.
DR   GO; GO:0060976; P:coronary vasculature development; ISO:RGD.
DR   GO; GO:0006887; P:exocytosis; ISO:RGD.
DR   GO; GO:0021592; P:fourth ventricle development; ISO:RGD.
DR   GO; GO:0007507; P:heart development; ISO:RGD.
DR   GO; GO:0001701; P:in utero embryonic development; ISO:RGD.
DR   GO; GO:0021670; P:lateral ventricle development; ISO:RGD.
DR   GO; GO:0000281; P:mitotic cytokinesis; ISO:RGD.
DR   GO; GO:0030239; P:myofibril assembly; ISO:RGD.
DR   GO; GO:0050885; P:neuromuscular process controlling balance; ISO:RGD.
DR   GO; GO:0001764; P:neuron migration; ISO:RGD.
DR   GO; GO:0031175; P:neuron projection development; ISO:RGD.
DR   GO; GO:0007097; P:nuclear migration; ISO:RGD.
DR   GO; GO:0001778; P:plasma membrane repair; ISO:RGD.
DR   GO; GO:0050714; P:positive regulation of protein secretion; ISO:RGD.
DR   GO; GO:0098974; P:postsynaptic actin cytoskeleton organization; ISO:RGD.
DR   GO; GO:0008360; P:regulation of cell shape; ISO:RGD.
DR   GO; GO:1905274; P:regulation of modification of postsynaptic actin cytoskeleton; IDA:SynGO.
DR   GO; GO:0060041; P:retina development in camera-type eye; ISO:RGD.
DR   GO; GO:0006930; P:substrate-dependent cell migration, cell extension; ISO:RGD.
DR   GO; GO:0021678; P:third ventricle development; ISO:RGD.
DR   GO; GO:0055015; P:ventricular cardiac muscle cell development; ISO:RGD.
DR   CDD; cd14920; MYSc_Myh10; 1.
DR   Gene3D; 1.10.10.820; -; 1.
DR   Gene3D; 1.10.287.1490; -; 1.
DR   Gene3D; 1.20.5.340; -; 5.
DR   Gene3D; 1.20.5.4820; -; 1.
DR   Gene3D; 1.20.58.530; -; 1.
DR   Gene3D; 6.10.250.2420; -; 1.
DR   Gene3D; 3.40.850.10; Kinesin motor domain; 1.
DR   Gene3D; 2.30.30.360; Myosin S1 fragment, N-terminal; 1.
DR   Gene3D; 1.20.120.720; Myosin VI head, motor domain, U50 subdomain; 1.
DR   InterPro; IPR000048; IQ_motif_EF-hand-BS.
DR   InterPro; IPR036961; Kinesin_motor_dom_sf.
DR   InterPro; IPR001609; Myosin_head_motor_dom.
DR   InterPro; IPR004009; Myosin_N.
DR   InterPro; IPR008989; Myosin_S1_N.
DR   InterPro; IPR002928; Myosin_tail.
DR   InterPro; IPR027417; P-loop_NTPase.
DR   PANTHER; PTHR45615; MYOSIN HEAVY CHAIN, NON-MUSCLE; 1.
DR   PANTHER; PTHR45615:SF24; MYOSIN-10; 1.
DR   Pfam; PF00612; IQ; 1.
DR   Pfam; PF00063; Myosin_head; 1.
DR   Pfam; PF02736; Myosin_N; 1.
DR   Pfam; PF01576; Myosin_tail_1; 1.
DR   PRINTS; PR00193; MYOSINHEAVY.
DR   SMART; SM00015; IQ; 1.
DR   SMART; SM00242; MYSc; 1.
DR   SUPFAM; SSF90257; Myosin rod fragments; 6.
DR   SUPFAM; SSF50084; Myosin S1 fragment, N-terminal domain; 1.
DR   SUPFAM; SSF52540; P-loop containing nucleoside triphosphate hydrolases; 1.
DR   PROSITE; PS50096; IQ; 1.
DR   PROSITE; PS51456; MYOSIN_MOTOR; 1.
DR   PROSITE; PS51844; SH3_LIKE; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Actin-binding; ATP-binding; Calmodulin-binding; Cell adhesion;
KW   Cell projection; Cell shape; Coiled coil; Methylation; Motor protein;
KW   Myosin; Nucleotide-binding; Phosphoprotein; Reference proteome.
FT   CHAIN           1..1976
FT                   /note="Myosin-10"
FT                   /id="PRO_0000123423"
FT   DOMAIN          31..81
FT                   /note="Myosin N-terminal SH3-like"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01190"
FT   DOMAIN          85..783
FT                   /note="Myosin motor"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00782"
FT   DOMAIN          786..815
FT                   /note="IQ"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00116"
FT   REGION          661..683
FT                   /note="Actin-binding"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00782"
FT   REGION          1125..1175
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1697..1718
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1874..1976
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COILED          845..1976
FT                   /evidence="ECO:0000255"
FT   COMPBIAS        1125..1156
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1697..1717
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1874..1915
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1950..1965
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   BINDING         178..185
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255"
FT   MOD_RES         18
FT                   /note="Omega-N-methylarginine"
FT                   /evidence="ECO:0000250|UniProtKB:Q61879"
FT   MOD_RES         442
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P35580"
FT   MOD_RES         1145
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         1241
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q61879"
FT   MOD_RES         1301
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q61879"
FT   MOD_RES         1645
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P35580"
FT   MOD_RES         1930
FT                   /note="Omega-N-methylarginine"
FT                   /evidence="ECO:0000250|UniProtKB:Q61879"
FT   MOD_RES         1935
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P35580"
FT   MOD_RES         1937
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P35580"
FT   MOD_RES         1938
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P35580"
FT   MOD_RES         1939
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P35580"
FT   MOD_RES         1940
FT                   /note="Omega-N-methylarginine"
FT                   /evidence="ECO:0000250|UniProtKB:Q61879"
FT   MOD_RES         1952
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         1956
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         1960
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:P35580"
FT   MOD_RES         1975
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
SQ   SEQUENCE   1976 AA;  228965 MW;  E32708BF9BF2B470 CRC64;
     MAQRTGLEDP ERYLFVDRAV IYNPATQADW TAKKLVWIPS ERHGFEAASI KEERGDEVMV
     ELAENGKKAM VNKDDIQKMN PPKFSKVEDM AELTCLNEAS VLHNLKDRYY SGLIYTYSGL
     FCVVINPYKN LPIYSENIIE MYRGKKRHEK PPHIYAISES AYRCMLQDRK DQSILCTGES
     GAGKTENTKK VIQYLAHVAS SHKGRKDHNI PGELERQLLQ ANPILESFGN AKTVKNDNSS
     RFGKFIRINF DVTGYIVGAN IETYLLEKSR AVRQAKDERT FHIFYQLLSG AGEHLKSDLL
     LEGFNNYRFL SNGYIPIPGQ QDKDNFQETM EAMHIMGFSH EEILSMLKVV SSVLQFGNIS
     FKKERNTDQA SMPENTVAQK LCHLLGMNVM EFTRAILTPR IKVGRDYVQK AQTKEQADFA
     VEALAKATYE RLFRWLVHRI NKALDRTKRQ GTSFIGILDI AGFEIFELNS FEQLCINYTN
     EKLQQLFNHT MFILEQEEYQ REGIEWNFID FGLDLQPCID LIERPANPPG VLALLDEECW
     FPKATDKTFV EKLVQEQGSH SKFQKPRQLK DKADFCIIHY AGKVDYKADE WLMKNMDPLN
     DNVATLLHQS SDRFVAELWK DVDRIVGLDQ VTGMTETAFG SAYKTKKGMF RNVGQLYKES
     LTKLMATLRN TNPNFVRCII PNHEKRAGKL DPHLVLDQLR CNGVLEGIRI CRQGFPNRIV
     FQEFRQRYEI LTPNAIPKGF MDGKQACERM IRALELDPNL YRIGQSKIFF RAGVLAHLEE
     ERDLKITDII IFFQAVCRGY LARKAFAKKQ QQLSALKVLQ RNCAAYLKLR HWQWWRVFTK
     VKPLLQVTRQ EEELQAKDEE LLKVKEKQTK VEGELEEMER KHQQLLEEKN ILAEQLQAET
     ELFAEAEEMR ARLAAKKQEL EEILHDLESR VEGEEERNQI LQNEKKKMQA HIQDLEEQLD
     EEEGARQKLQ LEKVTAEAKI KKMEEEVLLL EDQNSKFIKE KKLMEDRIAE CSSQLAEEEE
     KAKNLAKIRN KQEVMISDLE ERLKKEEKTR QELEKAKRKL DGETTDLQDQ IAELQAQVDE
     LKVQLTKKEE ELQGALARGD DETLHKNNAL KVARELQAQI AELQEDFESE KASRNKAEKQ
     KRDLSEELEA LKTELEDTLD TTAAQQELRT KREQEVAELK KALEDETKNH EAQIQDMRQR
     HATALEELSE QLEQAKRFKA NLEKNKQGLE TDNKELACEV KVLQQVKAES EHKRKKLDAQ
     VQELHAKVSE GDRLRVELAE KANKLQNELD NVSTLLEEAE KKGMKFAKDA AGLESQLQDT
     QELLQEETRQ KLNLSSRIRQ LEEEKNSLQE QQEEEEEARK NLEKQVLALQ SQLADTKKKV
     DDDLGTIEGL EEAKKKLLKD VEALSQRLEE KVLAYDKLEK TKNRLQQELD DLTVDLDHQR
     QIVSNLEKKQ KKFDQLLAEE KGISARYAEE RDRAEAEARE KETKALSLAR ALEEALEAKE
     EFERQNKQLR ADMEDLMSSK DDVGKNVHEL EKSKRALEQQ VEEMRTQLEE LEDELQATED
     AKLRLEVNMQ AMKAQFERDL QTRDEQNEEK KRLLLKQVRE LEAELEDERK QRALAVASKK
     KMEIDLKDLE AQIEAANKAR DEVIKQLRKL QAQMKDYQRE LEEARASRDE IFAQSKESEK
     KLKSLEAEIL QLQEELASSE RARRHAEQER DELADEIANS ASGKSALLDE KRRLEARIAQ
     LEEELEEEQS NMELLNDRFR KTTLQVDTLN TELAAERSAA QKSDNARQQL ERQNKELKAK
     LQELEGAVKS KFKATISALE AKIGQLEEQL EQEAKERAAA NKLVRRTEKK LKEIFMQVED
     ERRHADQYKE QMEKANARMK QLKRQLEEAE EEATRANASR RKLQRELDDA TEANEGLSRE
     VSTLKNRLRR GGPISFSSSR SGRRQLHIEG ASLELSDDDT ESKTSDVNET QPPQSE
//
